Quarterly report · Q3
8095.TEDINET S100S0V9
Period2022-12-01 → 2023-08-31
Filed2023-10-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥40.7bn | 2022-12-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥49.6bn | 2021-12-01 → 2022-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥36.9bn | 2021-12-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥685m | 2022-12-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥426m | 2021-12-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥790m | 2022-12-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2021-12-01 → 2022-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥517m | 2021-12-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥628m | 2022-12-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2021-12-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥210m | 2022-12-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥606m | 2021-12-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥201m | 2022-12-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥601m | 2021-12-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥67.1bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥62.9bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.9bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2022-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥27.2bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥27.1bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥27.1bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.2bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.9bn | at 2022-11-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥5.32 | 2022-12-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.08 | 2023-06-01 → 2023-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.56 | 2021-12-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.17 | 2021-12-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.19 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 40.4% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.0% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 61
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-12-01 → 2023-08-31 | ¥9m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-12-01 → 2023-08-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-12-01 → 2023-08-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-12-01 → 2023-08-31 | −¥78m |
| Reconciling Itemsreconciling | revenue | 2022-12-01 → 2023-08-31 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-12-01 → 2023-08-31 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-12-01 → 2023-08-31 | ¥69m |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue | 2022-12-01 → 2023-08-31 | ¥12.7bn |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-08-31 | ¥11.8bn |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-08-31 | ¥901m |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-08-31 | ¥63m |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2022-12-01 → 2023-08-31 | ¥12.7bn |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2022-12-01 → 2023-08-31 | ¥12.7bn |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2022-12-01 → 2023-08-31 | ¥68m |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2022-12-01 → 2023-08-31 | ¥191m |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue | 2022-12-01 → 2023-08-31 | ¥6.4bn |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-08-31 | ¥6.3bn |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-08-31 | ¥47m |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-08-31 | −¥49m |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue | 2022-12-01 → 2023-08-31 | ¥10.1bn |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue external | 2022-12-01 → 2023-08-31 | ¥9.8bn |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue intersegment | 2022-12-01 → 2023-08-31 | ¥294m |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | segment profit | 2022-12-01 → 2023-08-31 | ¥489m |
| —segment total | revenue | 2022-12-01 → 2023-08-31 | ¥42.0bn |
| —segment total | revenue external | 2022-12-01 → 2023-08-31 | ¥40.7bn |
| —segment total | revenue intersegment | 2022-12-01 → 2023-08-31 | ¥1.3bn |
| —segment total | segment profit | 2022-12-01 → 2023-08-31 | ¥694m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-08-31 | ¥42.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-08-31 | ¥40.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-12-01 → 2023-08-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-08-31 | ¥616m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-12-01 → 2022-08-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-12-01 → 2022-08-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-08-31 | −¥29m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-08-31 | −¥944m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-08-31 | −¥944m |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-08-31 | ¥119m |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥11.5bn |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥11.1bn |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥438m |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥10.5bn |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥105m |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-08-31 | −¥92m |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥70m |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-08-31 | −¥130m |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥9.3bn |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥8.9bn |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥331m |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | segment profit | 2021-12-01 → 2022-08-31 | ¥389m |
| —segment total | revenue | 2021-12-01 → 2022-08-31 | ¥37.9bn |
| —segment total | revenue external | 2021-12-01 → 2022-08-31 | ¥36.9bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥944m |
| —segment total | segment profit | 2021-12-01 → 2022-08-31 | ¥336m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-08-31 | ¥37.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-08-31 | ¥36.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥944m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-08-31 | ¥307m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 453
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember | 6529856000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 37870830000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1442000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 37872273000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -944127000 | JPY |
| Net sales | Prior1YTDDuration | 36928145000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember | 168829000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember | -91860000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember | 388873000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember | -130034000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 335809000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -28883000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 306925000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 119404000 | JPY |
| Operating income | Prior1YTDDuration | 426329000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember | 11847218000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember | 12651053000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember | 9845927000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember | 6323482000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 40667681000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 6865000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 40674547000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 40674547000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember | 900770000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember | 68125000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember | 293658000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember | 47006000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 1309560000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1871000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 1311431000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -1311431000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember | 12747989000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember | 12719178000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember | 10139585000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember | 6370489000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 41977242000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 8736000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 41985979000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -1311431000 | JPY |
| Net sales | CurrentYTDDuration | 40674547000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember | 63173000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember | 191120000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember | 488612000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember | -48686000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 694220000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -77793000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 616426000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | 68940000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |